Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

93
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
93
Cognitive Therapy01:25

Cognitive Therapy

145
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
145
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
Depression: Overview01:18

Depression: Overview

215
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
215
Theoretical Approaches to Psychological Disorder01:29

Theoretical Approaches to Psychological Disorder

93
The development of psychological disorders, which are characterized by deviant, maladaptive, and personally distressing behaviors, has been explored through several theoretical approaches.
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
93
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

49
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
49

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of a mobile-based self-management program on mental health in young adults: a randomized controlled trial.

Frontiers in public health·2026
Same author

Disparities in Initial Usage of Direct-to-Patient Teledermatology: A Retrospective Observational Study.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association·2026
Same author

Leadership Behaviors and Burnout in Healthcare: A Mixed-Methods Study in the Veterans Health Administration.

Journal of healthcare management / American College of Healthcare Executives·2026
Same author

Digital Mental Health Treatments for Depression.

The Psychiatric clinics of North America·2026
Same author

Popular Online Content as a Treatment-as-Usual Control in Digital Mental Health Intervention Trials: Secondary Analysis of Two Online Randomized Controlled Trials With Repeated Measures.

JMIR mental health·2026
Same author

Haemoglobin A1c Time-In-Range and Mortality in Adults With Diabetes.

Endocrinology, diabetes & metabolism·2026

Related Experiment Video

Updated: Jun 5, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K

Difficult to Treat Depression: Focus on Approach, Algorithms, and Access.

Jordan F Karp1, Roberta D Brinton2, Jay C Fournier3

  • 1Department of Psychiatry, College of Medicine, University of Arizona, Tucson.

The Journal of Clinical Psychiatry
|December 4, 2024
PubMed
Summary

Treating difficult to treat depression remains a challenge, especially for adults unresponsive to standard treatments. Experts convened to discuss novel approaches, evidence-based algorithms, and improved access to care for depression.

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.8K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.4K

Related Experiment Videos

Last Updated: Jun 5, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.8K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.4K

Area of Science:

  • Psychiatry and Mental Health
  • Neuroscience
  • Clinical Medicine

Background:

  • The COVID-19 pandemic increased focus on depression across all age groups.
  • Despite increased efforts, treating treatment-resistant depression in adults remains a significant challenge.
  • A shrinking psychiatric workforce exacerbates the difficulty in managing complex depression cases.

Purpose of the Study:

  • To address the challenges in treating difficult to treat depression.
  • To explore novel treatment mechanisms, evidence-informed algorithms, and access to care.
  • To foster discussion among experts on advancing depression treatment strategies.

Main Methods:

  • Convened 11 internationally renowned experts in depression science and treatment.
  • Organized the Southwest Forum on Difficult to Treat Depression in July 2024.
  • Focused discussions on three key themes: novel mechanisms, treatment algorithms, and care access.

Main Results:

  • Experts shared insights on novel mechanism approaches for difficult to treat depression.
  • Evidence-informed algorithms for faster patient improvement were discussed.
  • Strategies for improving access to comprehensive depression care were explored.

Conclusions:

  • Addressing difficult to treat depression requires a multi-faceted approach.
  • Advancements in understanding novel mechanisms and treatment algorithms are crucial.
  • Enhancing access to care is essential for managing depression across the spectrum of severity.